Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;120(13):1668-76; dicussion 1676-7.
doi: 10.1111/1471-0528.12428. Epub 2013 Sep 11.

Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study

B T Bateman  1 , S Hernandez-Diaz, K F Huybrechts, K Palmsten, H Mogun, J L Ecker, E W Seely, M A Fischer
Affiliations

Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study

B T Bateman et al. BJOG. 2013 Dec.

Abstract

Objective: To determine whether outpatient exposure to calcium-channel blockers (CCBs) at the time of delivery is associated with an increased risk for postpartum haemorrhage (PPH).

Design: Cohort study.

Setting: United States of America.

Population or sample: Medicaid beneficiaries.

Methods: We identified a cohort of 9750 patients with outpatient prescriptions for CCBs, methyldopa, or labetalol for pre-existing or gestational hypertension whose days of supply overlapped with delivery; 1226 were exposed to CCBs. The risk of PPH was compared in those exposed to CCBs to those exposed to methyldopa or labetalol. Propensity score matching and stratification were used to address potential confounding.

Main outcome measures: The occurrence of PPH during the delivery hospitalisation.

Results: There were 27 patients exposed to CCBs (2.2%) and 232 patients exposed to methyldopa or labetalol (2.7%) who experienced PPH. After accounting for confounders, there was no meaningful association between CCB exposure and PPH in the propensity score matched (odds ratio 0.77, 95% CI 0.50-1.18) or stratified (odds ratio 0.79, 95% CI 0.53-1.19) analyses. Similar results were obtained across multiple sensitivity analyses.

Conclusions: The outpatient use of CCBs in late pregnancy for the treatment of hypertension does not increase the risk of PPH.

Keywords: Calcium-channel blockers; hypertensive disorders of pregnancy; postpartum haemorrhage.

PubMed Disclaimer

Conflict of interest statement

Disclosures of interests: The Pharmacoepidemiology Program at the Harvard School of Public Health receives funding from Pfizer and Asisa. SHD has consulted for Novartis, GSK-Biologics and AstraZenaca for unrelated projects.

Figures

Figure 1
Figure 1
Patient flow chart
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM, et al. Maternal mortality for 181 countries, 1980–2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet. 2010 May 8;375(9726):1609–23. - PubMed
    1. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol. 2010 Dec;116(6):1302–9. - PubMed
    1. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010 May 1;110(5):1368–73. - PubMed
    1. Oyelese Y, Ananth CV. Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol. 2010 Mar;53(1):147–56. - PubMed
    1. Crozier TM, Wallace EM. Obstetric admissions to an integrated general intensive care unit in a quaternary maternity facility. Aust N Z J Obstet Gynaecol. 2011 Jun;51(3):233–8. - PubMed

Publication types